chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Never been so sick after I had to take the vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient been so sick after taken the Flu vaccine.  The patient refused before and refusing again. No contact details were provided.
Patient experienced a vasovagal event at the time of vaccine injection. Symptoms included syncope x 10 seconds, snorting, diaphoresis. After regaining consciousness, stated felt nauseous. All symptoms resolved in 5 minutes.
This spontaneous report was received from a pharmacist refers to a approximately 71 year old female patient. No medical history was reported. On 26-MAR-2013, the patient possibly was vaccinated with a dose of ZOSTAVAX (lot#, expiry, route not reported) but the pharmacist was not sure. No concomitant medications were reported. Since an unknown date, the patient had been experiencing an injection site reaction. The injection site was hard and there was a dark pigmented area that circled around the injection site. Patient sought medical attention-contacted pharmacy. The outcome of the events was reported as not recovered. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patient's medical history was not reported. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L038503, expiration date reported as 18-DEC-2017, lot #M005714, expiration date reported as 03-OCT-2017 (dose, route and site of administration were not reported) 4 doses were administered. There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 34 degrees Fahrenheit for 160 minutes. Data logger was involved. There were no previous excursions reported. Additional information has been requested.
Patient had received the Moderna vaccine for her 1st shot on 7/13/21 and was inadvertently given Pfizer today as her 2nd shot by the vaccinator.
Shortly after receiving vax, the pt stated she did not feel well and started talking funny. Her lips were blue and she was extremely pale and passed out. She was given ammonia, deep pain efforts, and two doses of epinephrine injections while trying to revive her. Her blood pressure and pulse were taken immediately after passing out.: BP 123/89, pulse 100; BP147/90, pulse 90; BP133/70, pulse 97. She was taken to the hospital and given Benadryl, and she started to revive after 30-45 minutes and was crying. Her potassium was 2.56 mEq/L. She told her parents she could hear everything and felt poking but could not respond. She was hurting all over and was weak. She especially had pain in her arm and throat.  She was having difficulty breathing. She was treated with a potassium bolus and given oxygen. She was transferred to another hospital and 1.5 - 2 hours post vax, she was alert but very achy and weak. A kidney ultrasound, chest x-ray, lupus and cancer tests, and blood tests were run and were normal. Her potassium was now 4.0 mEq/L. She was given potassium and magnesium tablets for 3 weeks which was stopped for observation for hypokalemic periodic paralysis, However, she never had another episode. The most recent information received reports the pt continues to have weakness and sever pain especially on her right side under rib above her breast into her back, described as a pinching feeling. Skelaxin is being taken with some relief. The pts mother stated the physician thought her daughter had a vasovagal event, but the clinic nurse thought differently.
the patient "squirmed."; Due to this movement "a little drop did not go in."; This spontaneous report was received from a healthcare professional referring to a 15-molth-old patient of unspecified gender. The patient's medical history, concurrent conditions, concomitant therapies, and previous drug reactions or allergies were not reported.   On an unspecified date, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (dose, vaccine scheme, route of administration, anatomical site of vaccination, lot number and expiration date were not reported) as prophylaxis. It was reported that the patient "squirmed" (discomfort). Due to this movement, a "little drop did not go in" (incorrect dose administered). The patient's physician requested information regarding revaccination.   The outcome of discomfort was unknown. The causal relationship between varicella virus vaccine live (Oka/Merck) (VARIVAX) and the event was not reported.
syncope, vagal response:  within one minute after administration, fainted.  Elevated feet prior to administration as he has history of fainting with shot administration.  Wife splashed water on his face, I placed cold wet compress at base of neck, we managed to contain him in chair with feet elevated.  took about  one minute to regain consciousness, BP readings were 84/54 mmHg HR 50, then 108/60mmHg HR 62 about 2 minutes later.  EMS was called as he was fainting.  They came and assessed him and diagnosed vagal response.  They left him at pharmacy to recover fully.  Last BP reading before leaving pharmacy was 95/65mmHg HR 62, about 10-15 minutes after.
Persistent pain; numbness in injection site and weakness distal to site, 1 month s/p immunization.
Context: Patient is a 54-year-old male who presents with right-sided flank pain, low back pain and right upper chest pain.  Patient has had the discomfort in the right flank radiating up into the right chest for about 2 weeks.  He states the pain in his chest is right upper chest, worse with breathing in and out.  He also has right flank pain and right lower lateral chest pain worse with breathing in and out.  Patient just developed dysuria with urinary frequency over the past 1 to 2 days.  He has had subjective fever, chills and significant diaphoresis at night.  He does have a history of multiple myeloma.  This was treated with a stem cell transplant in February of this year.  Patient and his wife report that recent laboratory data was concerning for possible recurrence and he had a bone marrow biopsy done about a month and 1/2-2 ago.  He is to have a repeat bone marrow biopsy tomorrow   Patient denies any midsternal chest pain.  No shortness of breath.  No cough or congestion.     Patient denies a history of blood clots.  Does have a history of heart disease, hypertension, hyperlipidemia.  Patient is morbidly obese.   Patient sees Dr. - oncology
On an unspecified date, the pt received a dose of Lymerix. The nurse reported that she had heard that the pt claimed he developed autoimmune arthritis. The most recent information received on 6/13/00, reports the outcome of the event as unknown. Additional information has been requested.
arm soreness a day after receiving her COVID 19 vaccination; This is a spontaneous report received from non-contactable reporter (Consumer or other non HCP) received by Pfizer from (Case ID: AE-2021-4453). The reporter is the patient. Other Case identifier(s): AE-2021-4453.  A 72 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 07Mar2021, outcome "unknown", described as "arm soreness a day after receiving her COVID 19 vaccination".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Soreness, ache around the injection site; Discomfort in her arm; This is a spontaneous report from a contactable consumer (patient herself).  This female patient (age not provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on 05Jan2021 at single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. On unknown date, the patient developed soreness, ache around the injection site. She had discomfort in her arm. She asked if could take ibuprofen (ADVIL) or acetylsalicylic acid (ASPIRIN) for her soreness. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
We had patients who were administered Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; vaccination date will be the start date of the event; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (We had patients who were administered Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (vaccination date will be the start date of the event) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021 at 3:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (We had patients who were administered Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (vaccination date will be the start date of the event). At the time of the report, PRODUCT STORAGE ERROR (We had patients who were administered Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (vaccination date will be the start date of the event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter  The Excursion duration was reported as 1 month.  No treatment medication was provided by the reporter.
her shoulder was turgid and red, was kind of blown up, and hard, and felt like a softball. It was a radius of about 2 inches around the injection site; her shoulder was turgid and red, was kind of blown up, and hard, and felt like a softball. It was a radius of about 2 inches around the injection site; her shoulder was turgid and red, was kind of blown up and hard, and felt like a softball. It was a radius of about 2 inches around the injection site; She noticed it was sore.  Since then it had gotten bigger and more sore; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on 22Jun2020 at single dose at left deltoid for susceptible to pneumonia based on previous hospitalizations. Medical history included obesity (she was on the low end of that due to her BMI) from 2016 to an unknown date, carrier for hemochromatosis genetically (she did not have a problem with it, she was just a carrier) from 07Sep1977, seasonal allergies, spring time and fall time (she was not on any medication and was not having any issues) start when she was 14-year-old, allergic to cats (the allergies began when she hit puberty) start also when she was around 14-year-old, hospitalized for severe pneumonia in 2016 and it was correlated to losing a pregnancy. She had Pneumonia in all 4 lobes of her lung. Her doctor told her that since she was susceptible, she should get the vaccine. There were no concomitant medications. Prior vaccinations within 4 weeks was none. She received the pneumococcal 13-val conj vac (dipht crm197 protein) vaccine on 22Jun2020 at 09:30 this morning maybe 09:45. She noticed right when she got home by 10:00-10:15. She noticed it was sore. Since then it had gotten bigger and more sore. Over the course of the day, her shoulder was turgid and red, was kind of blown up, and hard, and felt like a softball. It was a radius of about 2 inches around the injection site. She has not received any medical treatment. No AE required a visit to emergency room or physician's office. The outcome of events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
woke during night shaking, got up at 3:20 AM checked temperature 99.8 ,  took 2 Tylenol, within 60 minutes shaking stopped and while temperature remained at 99.8 60 minutes after 1st checked.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose number unknown (booster), single (Lot number: GH9702) at the age of 69 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Jan2023, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04Jan2023) Positive, notes: I tested positive for Covid on 04Jan23; (12Jan2023) Negative, notes: I tested negative on 12Jan23 and 13Jan2023; (13Jan2023) Negative, notes: I tested negative on 12Jan23 and 13Jan2023; (15Jan2023) Positive, notes: I tested positive again on the morning of 15Jan2023. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not receive other medication in 2weeks. Patient had no known allergies and patient was extremely healthy. I tested positive for Covid on 04Jan23 and was prescribed Paxlovid. I tested negative on 12Jan23 and 13Jan2023 and then had a rebound on the evening of 14Jan2023 from taking Paxlovid. I tested positive again on the morning of 15Jan2023 with much more sever cold symptoms. Treatment start date was 04Jan2023 and stop date was 08Jan2023.  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.
This case was reported by a nurse and described the occurrence of chest pain in a 43 year old female subject who was vaccinated with Twinrix for prophylaxis. Medical history included codeine allergy and migraine. Concurrent medications included Imitrex for migraine and Allegra, Doxepin, Wellbutrin and Zonegran for unspecified drug indications. The subject told the nurse that at the time of receipt of the vaccinations she, "was very stressed about traveling." On 5 August 2005 the subject received the 1st dose of Twinrix (lot AHABA016AA). On 05 August 2005, the subject was also vaccinated with Typhim Vi and tetanus toxoid vaccine. "Within 24 hours" following the receipt of the vaccinations. On 06 August 2005, the subject experienced chest pain described as mild tightness. The subject was seen by her "regular physician." The events resolved on an unspecified date on or after 06 August 2005 and on or before 02 September 2005. The nurse considered the events to possibly be related to vaccination with Twinrix. Follow up will not be available.
Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and VOMITING (Vomiting) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Patient developed a rash both hands 1 week after Zostavax injection, he tried hydrocortisone that made the rash worse. I saw him today and the rash is almost gone.
ARM WAS A LITTLE BIT SORE AT THE INJECTION SITE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry: UNKNOWN) dose was not reported, administered on MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced arm was a little bit sore at the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of arm was a little bit sore at the injection site was not reported. This report was non-serious.
Information has been received from a licensed practical nurse concerning a female with no medical history or drug allergies who was vaccinated with the first and second doses of MMR II at her 15 months of age and 4 years of age, respectively. There was no concomitant medication. Subsequently, the now 26 year old patient had tested negative for rubeola antibody titers. The outcome was not reported. The patient sought unspecified medical attention. Additional information has been requested.
headache; diarrhea; stomach ache; tired; This is a spontaneous report from a contactable consumer (patient's mother) via medical information team. A 13-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0182), via an unspecified route of administration in Arm Left on 25May2021 at 13:00 (13-years-old at the time of vaccination) as single dose for COVID-19 immunization. The patient's medical history included mental problem (reported that she takes a medicine for a mental problem that she has but the caller does not know the name of the medication or the condition). The patient had no family medical history relevant to adverse events. The patient did not receive other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient's concomitant medications were not reported. The patient's weight is 200 something. On 25May2021, the patient experienced headache, diarrhea, stomach-ache and was tired. Clinical course included: headache began after the shot yesterday (25May2021); diarrhea and stomach-ache began last night. Her daughter was also tired, she just said she was going to go take a nap now. The tiredness also started yesterday because she laid down with the headache, so it had to be yesterday. The tiredness was persisting about the same, caller's spouse can be heard in the background of the call saying everything was persisting about the same. The outcome of events was not recovered.  Additional information is requested.
welts all over neck; broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 20-Jan-2021.    A spontaneous report (United States) was received from a 55 years female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced welts all over neck broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 14-Jan-2021, prior to the onset of the events welts all over neck broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 025J20-2A) via intramuscular route in right arm for prophylaxis of COVID-19 infection.  On 19-Jan-2021, the patient experienced welts all over neck broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck.  Patient received hydroxyzine pamoate 25mg capsules, Famotidine 40mg and Prednisone 20mg as treatments drugs.  Action taken with mRNA-1273 in response to the events welts all over neck broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck was not provided.  The outcome of the events welts all over neck broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck was not provided.  The reporter did not provide the assessment of the events welts all over neck broke out in a rash/bumps all over leg/and going to her other leg/it's on her neck to study drug.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Two days after receiving DTaP and IPV vaccine injections in his left arm, he awoke with swelling/induration and erythema of almost entire left upper arm. Not ill appearing. T 99 (oral).
This spontaneous report was received from a healthcare worker referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On 17-FEB-2016, the patient was vaccinated with a dose of GARDASIL (lot # L020015 and expiration date August 2017, unknown route), which was exposed to temperatures outside of the recommended range. There were no concomitant medications provided. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Since the night of my shot, I have had the chills, fever, muscle and bodyaches, I can?t move my left arm where I got the shot, and it hurts to walk. I can?t keep food down and I am incredibly thirsty
Sore arm at injection site, slight nausea, some chills, tired and small headache. Started around 2 pm day of the shot with a sore arm. Then progressed into the evening around 6 pm with the other effects, fingers are cold too.
Little soreness in arm where I got the shot; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.    Additional Information: GSK Receipt Date: 14-OCT-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient stated that, aside from a little soreness in his/her arm where he/she got the shingles shot, the patient had no negative reaction at all. Additional Supportive Information: The follow up would not possible as no contact details were available.
PATIENT REPORTS SIGNIFACANT LOSS OF HAIR SINCE VACCINE WAS GIVEN.